title: Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Vitale
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lombardi
authors.forename: Rafael
authors.initials: R
authors.lastname: Ramirez Morales
authors.forename: Umberto
authors.initials: U
authors.lastname: Cillo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib